Cocrystal Pharma, Inc. · NASDAQ:COCP
OPKO HEALTH, INC. reported a 29.60% stake in Cocrystal Pharma, Inc. (Schedule 13D)
Event Jul 31, 2026 · Filed Aug 7, 2026
OPKO HEALTH, INC. reported a 29.60% stake in Cocrystal Pharma, Inc., 5,692,916 shares, with active intent on Jul 31, 2026. Filed Aug 7, 2026 (Schedule 13D).
- Stake
- 29.60%
- Shares
- 5,692,916
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| OPKO HEALTH, INC. | 29.60% | 5,692,916 |
| FROST PHILLIP MD ET AL | 13.90% | 2,786,412 |
| Frost Gamma Investments Trust | 13.60% | 2,712,977 |
| Rubin Steven D | 14.10% | 2,724,860 |
Source
Related
- Cocrystal Pharma, Inc.
- Opko Health, Inc.
- Cocrystal Pharma, Inc. shareholders
- Schedule 13D/A · Frost Gamma Investments Trust · Aug 7, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 6, 2026
- Form 4 · Frost Gamma Investments Trust · Aug 5, 2026
- Schedule 13D/A · Frost Gamma Investments Trust · Oct 30, 2025
- Schedule 13D/A · Frost Gamma Investments Trust · Oct 2, 2025